Omaveloxolone approved for patients aged 16 years and older with Friedreich ataxia (FRDA): A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG)

Omaveloxolone approved for patients aged 16 years and older with Friedreich ataxia (FRDA): A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG)

Bibliographic Details
Main Authors: Arthur Lenahan, Sho Yano, Brett Graham, Kuntal Sen
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:Genetics in Medicine Open
Subjects:
Friedreich ataxia
Neuromuscular medicine
Omaveloxolone
Orphan drug
Precision medicine
Online Access:http://www.sciencedirect.com/science/article/pii/S2949774423008415

Similar Items

Similar Items